A recent study compared the cost of 33 neurologic drugs via a direct-to-consumer (DTC) pharmacy and via commercial insurance.

Forbes contributors publish independent expert analyses and insights. Sally Pipes is a scholar and think tank CEO who writes on health care. "By embracing a DTC sales model, pharmaceutical companies ...

(Reuters) -Several pharmaceutical companies have said they will sell drugs direct to patients in the U.S. and offered ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Among the demands that ...

A new study offers a glimpse at how direct-to-consumer pharmacy pricing could one day present stiff competition to the private prescription drug insurance model, researchers say.

Forbes contributors publish independent expert analyses and insights. I'm a freelance writer specializing in retail and ecommerce. The fragrance category represents an opportunity to capitalize on ...

Ohio State University study suggests Mark Cuban's pharmacy may offer lower costs than traditional insurance for neurologic medications.

When it comes to health and wellness, few things matter more than trust. For 50+-year-old people who navigate the aches, pains, and uncertainties, they need a product that actually works and feels ...

Several pharmaceutical companies have said they will sell drugs direct to patients in the U.S. and offered discounts ...